Cancer Biology & Molecular Oncology focuses on understanding the fundamental biological and molecular mechanisms that drive cancer initiation, progression, metastasis, and therapeutic resistance. This field explores the genetic, epigenetic, and cellular alterations that transform normal cells into malignant tumors, providing critical insights into tumor development and disease progression. Advances in molecular oncology have significantly improved the identification of cancer biomarkers, molecular targets, and signaling pathways, enabling more accurate diagnosis and the development of personalized treatment strategies.
This scientific track highlights the latest research in tumor biology, oncogenes and tumor suppressor genes, cell signaling pathways, cancer genomics, epigenetics, the tumor microenvironment, molecular diagnostics, and targeted therapeutics. It provides a platform for researchers, clinicians, and industry experts to discuss emerging discoveries, innovative technologies, and translational approaches that are advancing precision oncology and improving outcomes for cancer patients worldwide.
